<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4347</id>
  <title>T3D4293</title>
  <common-name>Uracil</common-name>
  <description>Uracil is a common naturally occurring pyrimidine found in RNA, it base pairs with adenine and is replaced by thymine in DNA. Methylation of uracil produces thymine. Uracil's use in the body is to help carry out the synthesis of many enzymes necessary for cell function through bonding with riboses and phosphates. Uracil serves as allosteric regulator and coenzyme for many important biochemical reactions. UDP and UTP regulate CPSase II activity in animals. UDP-glucose regulates the conversion of glucose to galactose in the liver and other tissues in the process of carbohydrate metabolism. Uracil is also involved in the biosynthesis of polysaccharides and the transportation of sugars containing aldehydes.</description>
  <cas>66-22-8</cas>
  <pubchem-id>1174</pubchem-id>
  <chemical-formula>C4H4N2O2</chemical-formula>
  <weight nil="true"/>
  <appearance>White powder.</appearance>
  <melting-point>330°C</melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility>3.6 mg/mL</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>This is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2014-08-29T06:16:24Z</created-at>
  <updated-at type="dateTime">2026-05-14T17:49:55Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Uracil</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id>C00106</kegg-compound-id>
  <omim-id nil="true"/>
  <chebi-id>17568</chebi-id>
  <biocyc-id>URACIL</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB03419</drugbank-id>
  <pdb-id>URA</pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>O=C1NC=CC(=O)N1</moldb-smiles>
  <moldb-formula>C4H4N2O2</moldb-formula>
  <moldb-inchi>InChI=1S/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8)</moldb-inchi>
  <moldb-inchikey>ISAKRJDGNUQOIC-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">112.0868</moldb-average-mass>
  <moldb-mono-mass type="decimal">112.027277382</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Solid</state>
  <logp>-1.07</logp>
  <hmdb-id>HMDB00300</hmdb-id>
  <chembl-id>CHEMBL566</chembl-id>
  <chemspider-id>1141</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Kurt Klemm, Wolfgang Schoetensack, Wolfgang Prusse, &amp;#8220;Aryl-substituted piperazinyl-alkylamino-uracils, -uracil ethers and -uracil thioethers and method for their production.&amp;#8221; U.S. Patent US3957786, issued September, 1951.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003253</chemdb-id>
  <dsstox-id>DTXSID4021424</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00002070</susdat-id>
  <iupac>1,2,3,4-tetrahydropyrimidine-2,4-dione</iupac>
  <moldb-polar-surface-area>58.2</moldb-polar-surface-area>
  <moldb-refractivity>25.9693</moldb-refractivity>
  <moldb-polarizability>9.36551055096874</moldb-polarizability>
  <moldb-rotatable-bond-count>0</moldb-rotatable-bond-count>
  <moldb-acceptor-count>2</moldb-acceptor-count>
  <moldb-donor-count>2</moldb-donor-count>
  <moldb-pka-strongest-acidic>8.803392786213806</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>-5.5116186106121114</moldb-pka-strongest-basic>
  <moldb-physiological-charge>0</moldb-physiological-charge>
  <moldb-number-of-rings>1</moldb-number-of-rings>
  <moldb-alogps-logp>-1.20</moldb-alogps-logp>
  <moldb-alogps-logs>-0.63</moldb-alogps-logs>
  <moldb-alogps-solubility>2.65e+01 g/l</moldb-alogps-solubility>
</compound>
